5th In Vivo Cell Engineering and Gene Editing Summit Hotel Commonwealth, Boston

Unlock the next frontier of cell and gene therapies at the 5th In Vivo Cell Engineering and Gene Editing Summit. This meeting is the leading industry forum dedicated to advancing in vivo delivery modalities, editing technologies, payload design, and translational strategies.

This summit brings together pioneering scientists, biotech innovators, regulatory experts, and therapeutic developers who are shaping the future of in vivo gene engineering. The program is designed to help teams accelerate therapeutic development, overcome translational challenges, and build safer, more precise in vivo editing platforms.

Key themes include:
– Next-generation delivery systems for in vivo gene engineering
– Advances in CRISPR, base editing, prime editing, and programmable nucleases
– Novel vectors, nanoparticles, and targeted delivery strategies
– Safety, durability, biodistribution, and immunogenicity considerations
– Regulatory insights and clinical development pathways
– Real-world case studies from leading biotech and pharma innovators

Whether you’re working in ex vivo and looking to add in vivo to your pipeline, or have cemented your work in in vivo already, this summit offers unparalleled access to the experts and insights driving the field forward.